Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page
- Check5 days agoChange DetectedUpdates the ClinicalTrials.gov page’s revision/version indicator from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check55 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check77 days agoChange DetectedFallopian tube cancer is now listed as a condition on the page, and the page revision updated to v3.4.2 (replacing v3.4.1).SummaryDifference0.1%

- Check84 days agoChange DetectedAdded 'Primary peritoneal carcinoma' to the conditions/terms and introduced a resources entry for the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check85 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1. This appears to be a behind-the-scenes update with no visible changes to the study details or page content.SummaryDifference0.0%

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.